Wells Fargo stays bullish on Thermo Fisher Scientific, noting positive earnings and growth prospects

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 11 Best 52-Week Low Stocks to Buy Right Now, with Wells Fargo maintaining a Buy rating and a price target of $570. Analyst Brandon Couillard noted a revised acquisition deal with Solventum Corp (NYSE:SOLV), excluding the Drinking Water Filtration business, reducing the purchase price to $4.0 billion.

The deal revision is expected to be accretive to TMO’s earnings per share, aligning with the company’s focus on higher-margin segments for stronger earnings growth. TMO has shown consistent quarter-over-quarter improvement in core growth, aiming for 5% core growth in 2025 and long-term organic growth of 7-9%, with significant operational margin expansion.

Thermo Fisher Scientific Inc. (NYSE:TMO) is a leading company in the life sciences and diagnostics industry. While TMO shows investment potential, some believe certain AI stocks offer greater upside potential with less downside risk. For those interested in undervalued AI stocks, a free report on the best short-term AI stock is available.

Disclosure: None.

Read more at Yahoo Finance: Wells Fargo maintained a Buy rating on Thermo Fisher Scientific (TMO)